Home
Conditions
Vector Borne Diseases

Clinical trial condition

Vector Borne Diseases

Explore clinical trials studying Vector Borne Diseases. Study availability and eligibility vary by location and protocol.

2,038 public trials 145 recruiting studies

Refine in advanced search Browse all conditions

Vector Borne Diseases trial results

Completed

Evaluation of G-CSF (Colony Stimulating Factor) in Patients With Chronic Chagas Cardiomyopathy

NCT02154269

Conditions: Chagas Disease, Chronic Chagasic Myocarditis, Euglenozoa Infections, +5 more
Locations: Hospital São Rafael Salvador, Estado de Bahia, Brazil

View Trial Details

Completed

Vaccination Trial of a Recombinant MVA-BN-WEV Vaccine in Healthy Adult Subjects

NCT04131595

Conditions: Alphavirus Infections, Arbovirus Infections, Brain Diseases, +18 more
Locations: Johnson County Clin-Trials Lenexa, Kansas, United States

View Trial Details

Completed

Microvascular Endothelial Function in a Cohort of Patients With the Cardiac Form of Chronic Chagas Disease.

NCT03524768

Conditions: Cardiomyopathies, Cardiovascular Diseases, Chagas Cardiomyopathy, +8 more
Locations: National Institute of Cardiology, Ministry of Health, Brazil Rio de Janeiro, Brazil

View Trial Details

Completed

Epidemiology Study of Malaria Transmission Intensity in Africa

NCT01190202

Conditions: Infections, Malaria, Malaria Vaccines, +5 more
Locations: GSK Investigational Site Ouagadougou, Burkina Faso

GSK Investigational Site Lambaréné, Gabon

GSK Investigational Site Kintampo, Ghana

GSK Investigational Site Kumasi, Ghana

View Trial Details

Completed

A Study to Evaluate the Efficacy, Immunogenicity and Safety in a Sporozoite Challenge Model of a Fractional Booster Dose of GSK Biologicals' Candidate Malaria Vaccine Administered to Previously Vaccinated Healthy Malaria-naïve Adults

NCT03824236

Conditions: Infections, Malaria, Mosquito-Borne Diseases, +3 more
Locations: GSK Investigational Site Silver Spring, Maryland, United States

View Trial Details

Completed

Safety and Immunogenicity of a First-in-Human Mosquito Saliva Peptide Vaccine

NCT03055000

Conditions: Infections, Mosquito-Borne Disease, Mosquito-Borne Diseases, +1 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Completed

Performance of RPA-LF for Cutaneous Leishmaniasis

NCT04500873

Conditions: Cutaneous Leishmaniasis (Diagnosis), Disease, Euglenozoa Infections, +12 more
Locations: Corporación Centro Internacional de entrenamiento e Investigaciónes Médicas Cali, Valle del Cauca Department, Colombia

View Trial Details

Completed

Randomized Single-Blinded Study to Evaluate Safety and Immunogenicity of Recombinant Plague Vaccine With and Without Adjuvant

NCT01122784

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Enterobacteriaceae Infections, +6 more
Locations: Benchmark Research San Francisco, California, United States

Apex Research Institute Santa Ana, California, United States

Johnson County Clinical Trials Lenexa, Kansas, United States

Heartland Reseach Assoicates, LLC Wichita, Kansas, United States

View Trial Details

Completed

Efficacy and Safety Study of Tafenoquine (TQ) Co-administered With Dihydroartemisinin-piperaquine (DHA-PQP) for the Radical Cure of Plasmodium Vivax (P. Vivax) Malaria

NCT02802501

Conditions: Infections, Malaria, Malaria, Vivax, +4 more
Locations: GSK Investigational Site Jakarta, Indonesia

View Trial Details

Completed

Targeted Indoor Residual Spraying Against Malaria

NCT02556242

Conditions: Infections, Malaria, Mosquito-Borne Diseases, +3 more
Locations: Provincial Malaria Control Programme Tzaneen, Limpopo, South Africa

Provincial Malaria Control Programme Mbombela, Mpumalnga, South Africa

View Trial Details

Vector Borne Diseases

Vector Borne Diseases trial results

Related conditions